131 related articles for article (PubMed ID: 35594711)
1. Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis.
George J; Tsuchishima M; Tsutsumi M
Biomed Pharmacother; 2022 Jul; 151():113111. PubMed ID: 35594711
[TBL] [Abstract][Full Text] [Related]
2. MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice.
George J; Tsutsumi M; Tsuchishima M
J Cell Mol Med; 2017 Dec; 21(12):3821-3835. PubMed ID: 28782260
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.
Arffa ML; Zapf MA; Kothari AN; Chang V; Gupta GN; Ding X; Al-Gayyar MM; Syn W; Elsherbiny NM; Kuo PC; Mi Z
PLoS One; 2016; 11(12):e0167435. PubMed ID: 27935974
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.
Urtasun R; Lopategi A; George J; Leung TM; Lu Y; Wang X; Ge X; Fiel MI; Nieto N
Hepatology; 2012 Feb; 55(2):594-608. PubMed ID: 21953216
[TBL] [Abstract][Full Text] [Related]
5. Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.
Arriazu E; Ge X; Leung TM; Magdaleno F; Lopategi A; Lu Y; Kitamura N; Urtasun R; Theise N; Antoine DJ; Nieto N
Gut; 2017 Jun; 66(6):1123-1137. PubMed ID: 26818617
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis.
Zhen MC; Wang Q; Huang XH; Cao LQ; Chen XL; Sun K; Liu YJ; Li W; Zhang LJ
J Nutr Biochem; 2007 Dec; 18(12):795-805. PubMed ID: 17481882
[TBL] [Abstract][Full Text] [Related]
8. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
9. Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats.
George J; Tsutsumi M; Takase S
Int J Biochem Cell Biol; 2004 Feb; 36(2):307-19. PubMed ID: 14643895
[TBL] [Abstract][Full Text] [Related]
10. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice.
Tipoe GL; Leung TM; Liong EC; Lau TY; Fung ML; Nanji AA
Toxicology; 2010 Jun; 273(1-3):45-52. PubMed ID: 20438794
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin delays resolution of liver fibrosis.
Leung TM; Wang X; Kitamura N; Fiel MI; Nieto N
Lab Invest; 2013 Oct; 93(10):1082-9. PubMed ID: 23999249
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol mitigate structural changes and hepatic stellate cell activation in N'-nitrosodimethylamine-induced liver fibrosis via restraining oxidative damage.
Ahmad A; Ahmad R
Chem Biol Interact; 2014 Sep; 221():1-12. PubMed ID: 25064540
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective effect of juglone on dimethylnitrosamine-induced liver fibrosis and its effect on hepatic antioxidant defence and the expression levels of α-SMA and collagen III.
Zhou DJ; Mu D; Jiang MD; Zheng SM; Zhang Y; He S; Weng M; Zeng WZ
Mol Med Rep; 2015 Sep; 12(3):4095-4102. PubMed ID: 26126609
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of gallic acid on CCl4-mediated liver fibrosis in mice.
Wang J; Tang L; White J; Fang J
Cell Biochem Biophys; 2014 May; 69(1):21-6. PubMed ID: 24096707
[TBL] [Abstract][Full Text] [Related]
17. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis.
Cui G; Chen J; Wu Z; Huang H; Wang L; Liang Y; Zeng P; Yang J; Uede T; Diao H
J Cell Physiol; 2019 Jun; 234(6):8988-8997. PubMed ID: 30350863
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic implication of human placental extract to prevent liver cirrhosis in rats with metabolic dysfunction-associated steatohepatitis.
Yamagata M; Tsuchishima M; Saito T; Tsutsumi M; George J
Clin Sci (Lond); 2024 Mar; 138(5):327-349. PubMed ID: 38381799
[TBL] [Abstract][Full Text] [Related]
20. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
